The sepsis diagnostics market is expected to gain a
market value of USD 1,582.23 million by 2030 at a CAGR of 9.80% over the
forecast period of 2022-2030.
The market’s historical growth trajectory, present conditions, and
future growth prospects are studied in the report. The report provides a
comprehensive overview of the market’s historical growth trajectory by
detailing the historical stats regarding the market. Future projections are
based on the detailed historical stats offered in the report. Based on this
platform, future projections for the sepsis diagnostics market’s growth
trajectory over the forecast period are provided in the report. The report also
profiles the leading players in the global sepsis diagnostics market and gives
readers a comprehensive analysis of the leading players in the global sepsis
diagnostics market. The report also profiles the major drivers and restraints
affecting the global sepsis diagnostics market. The factors making the market
tick and those holding the market back are studied in detail in the report. The
impact of the COVID-19 pandemic on the sepsis diagnostics market is also
assessed in the report.
Sepsis diagnostics can be used to diagnose severe sepsis as well as
septic shock, which differ slightly in symptoms. Severe sepsis can cause an
organ to fail, whereas septic shock is manifested through various symptoms,
including low blood pressure. The rising prevalence of sepsis is the primary
driver for the global sepsis diagnostics market. Sepsis is a life-threatening
complication of the body’s own immune system hurting the body’s own organs or
tissues. It can be caused by a weakened immune system, chronic disease, cancer,
or kidney or liver diseases.
Major Key
Players:
The Sepsis
Diagnostics Market Players are EKF Diagnostics (UK), T2
Biosystems, Inc. (US), bioMérieux, Inc. (US), Becton, Dickinson and Company
(US), Sandstone Diagnostics, Inc. (US), Immunexpress (US), Axis-Shield
Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), and others.
Segment Analysis
The global sepsis
diagnostics market is segmented on the basis of technology, product, end use,
and region.
By technology,
the global sepsis diagnostics market is segmented into molecular diagnostics,
biomarkers, immunoassays, and others. The molecular diagnostics segment holds
the largest share in the global sepsis diagnostics market and is likely to
remain the leading revenue generator over the forecast period. Molecular
diagnostics are highly effective diagnosing sepsis. However, the slowness of
molecular diagnostics processes is likely to count against them in the final
reckoning over the coming years. Alternative technologies are likely to be
developed in the coming years in order to counter the slow nature of molecular
diagnostics. The biomarkers segment also accounts for a significant share in
the global sepsis diagnostics market.
On the basis of
product type, the global sepsis diagnostics market is segmented into kits,
instruments, blood culture media, and others. The kits segment holds a major
share in the global sepsis diagnostics market.
On the basis of
end user, the global sepsis diagnostics market is segmented into pathology
laboratories, specialty clinics, hospitals, diagnostic centers, and others.
Regional Analysis
The region-based study of the
sepsis diagnostic market includes regions such as Americas, Europe, Asia
Pacific, Middle East, and Africa. The North American region is the major market
for medical tourism which is expected to motivate the development of the sepsis
market in the forecast period. The North American market for sepsis diagnostics
is anticipated to achieve USD 320 million by the end of the forecasted period.
The European region is the next prime market for sepsis diagnostics which is
anticipated to develop at the CAGR of 6.8%. While the Asia Pacific region is
anticipated to be the most rapidly growing region in sepsis diagnostics market.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
